American Society of Addiction Medicine

The American Board of Medical Specialties’ (ABMS) approval of a four-year extension of the practice pathway in Addiction Medicine. This extension will allow physicians with substantial experience in the practice of Addiction Medicine, but who have not completed an ACGME-accredited fellowship in Addiction Medicine, to apply for the Addiction Medicine certification exam through the 2025 Exam Cycle.

ASAM has updated its FREE guidance documents and resources to reflect the current environment across multiple areas and a variety of practice settings. Over 15 individual guidance documents are available.

The office of the Inspector General at HHS released rules which shows they are not expanding the patient engagement and support safe harbor to include cash and cash-equivalent payments offered as part of contingency management interventions or other programs to motivate beneficial behavioral changes.

ASAM sent a letter to congressional leadership opposing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019, which would, among other things, completely remove cannabis from the list of scheduled substances under the Controlled Substances Act (CSA).

ASAM, the Campaign for Tobacco-Free Kids, and 67 partner organizations sent a letter to Food and Drug Administration (FDA) Commissioner Stephen Hahn urging him to commence rulemaking to prohibit menthol as a characterizing flavor in cigarettes.